[Background data of spontaneous tumors in F344/DuCrlCrlj rats]. 2015

Kenji Takanobu, and Shigetoshi Aiso, and Yumi Umeda, and Hideki Senoh, and Misae Saito, and Taku Katagiri, and Naoki Ikawa, and Hiroaki Ishikawa, and Takashi Mine, and Makoto Take, and Mitsuru Haresaku, and Michiharu Matsumoto, and Shoji Fukushima
Japan Bioassay Research Center, Japan Industrial Safety and Health Association, 2445, Hirasawa, Hadano, Kanagawa 257-0015, Japan.

BACKGROUND We investigated the 2-year survival rate and incidence of spontaneous tumors in F344/DuCrlCrlj rats used in carcinogenicity studies of chemical substances. Records for animals used in the control groups of carcinogenicity studies which were conducted during the last 10 years were obtained from the database of the Japan Bioassay Research Center (JBRC). Six hundred ninety-nine males and 550 females were used in 14 and 11 inhalation studies, respectively, and 500 animals of each sex were used in 10 male and 10 female oral studies. METHODS In each study, SPF (specific pathogen free) animals were housed for 2 years (104 weeks) as control groups in the carcinogenicity studies. All animals underwent necropsy and histopathological examination. Each study was conducted in accordance with the Good Laboratory Practice. RESULTS The incidence of interstitial cell tumors was highest in both inhalation studies and oral studies (inhalation studies 86.1%, oral studies 68.6%). Tumors which had an incidence of 6% or higher were adenoma of the pituitary, C-cell adenoma of the thyroid, and mononuclear cell leukemia (LGL leukemia) of the spleen in male and female rats; fibroma of the subcutaneous tissue, adrenal pheochromocytoma, and islet cell adenoma of the pancreas in male rats; and endometrial stromal polyps and fibroadenoma of the mammary gland in female rats. Tumors other than the above had rare incidence rates. A clear difference in the incidence of spontaneous tumors was not observed between the inhalation and oral studies. The incidences of spontaneous tumors in control groups of previous oral studies are similar to our findings. There are no other reports of the spontaneous tumor incidence in the control groups of inhalation studies using F344/DuCrlCrlj rats. The 2-year survival rate was about 77% in both the inhalation and oral studies, and a gender difference was not observed. The F344/DuCrlCrlj rats used at JBRC had a higher 2-year survival rate than F344/N rats. This difference is possibly due to the low incidence of LGL leukemia in the F344/DuCrlCrlj rat. CONCLUSIONS The incidences of spontaneous tumors in F344/DuCrlCrlj rats used in control groups of both inhalation and oral studies during the last 10 years at JBRC are similar to each other and similar to those reported in other studies. This is the first report on the incidence of spontaneous tumors in inhalation studies and contributes to the toxicological evaluation of studies using F344/DuCrlCrlj rats.

UI MeSH Term Description Entries
D008297 Male Males
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D005260 Female Females
D000280 Administration, Inhalation The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract. Drug Administration, Inhalation,Drug Administration, Respiratory,Drug Aerosol Therapy,Inhalation Drug Administration,Inhalation of Drugs,Respiratory Drug Administration,Aerosol Drug Therapy,Aerosol Therapy, Drug,Drug Therapy, Aerosol,Inhalation Administration,Administration, Inhalation Drug,Administration, Respiratory Drug,Therapy, Aerosol Drug,Therapy, Drug Aerosol
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000830 Animals, Laboratory Animals used or intended for use in research, testing, or teaching. Laboratory Animals,Animal, Laboratory,Laboratory Animal
D012376 Rodent Diseases Diseases of rodents of the order RODENTIA. This term includes diseases of Sciuridae (squirrels), Geomyidae (gophers), Heteromyidae (pouched mice), Castoridae (beavers), Cricetidae (rats and mice), Muridae (Old World rats and mice), Erethizontidae (porcupines), and Caviidae (guinea pigs). Disease, Rodent,Diseases, Rodent,Rodent Disease

Related Publications

Kenji Takanobu, and Shigetoshi Aiso, and Yumi Umeda, and Hideki Senoh, and Misae Saito, and Taku Katagiri, and Naoki Ikawa, and Hiroaki Ishikawa, and Takashi Mine, and Makoto Take, and Mitsuru Haresaku, and Michiharu Matsumoto, and Shoji Fukushima
October 1986, Jikken dobutsu. Experimental animals,
Kenji Takanobu, and Shigetoshi Aiso, and Yumi Umeda, and Hideki Senoh, and Misae Saito, and Taku Katagiri, and Naoki Ikawa, and Hiroaki Ishikawa, and Takashi Mine, and Makoto Take, and Mitsuru Haresaku, and Michiharu Matsumoto, and Shoji Fukushima
January 2021, Journal of toxicologic pathology,
Kenji Takanobu, and Shigetoshi Aiso, and Yumi Umeda, and Hideki Senoh, and Misae Saito, and Taku Katagiri, and Naoki Ikawa, and Hiroaki Ishikawa, and Takashi Mine, and Makoto Take, and Mitsuru Haresaku, and Michiharu Matsumoto, and Shoji Fukushima
June 2013, Journal of toxicologic pathology,
Kenji Takanobu, and Shigetoshi Aiso, and Yumi Umeda, and Hideki Senoh, and Misae Saito, and Taku Katagiri, and Naoki Ikawa, and Hiroaki Ishikawa, and Takashi Mine, and Makoto Take, and Mitsuru Haresaku, and Michiharu Matsumoto, and Shoji Fukushima
January 1986, Neoplasma,
Kenji Takanobu, and Shigetoshi Aiso, and Yumi Umeda, and Hideki Senoh, and Misae Saito, and Taku Katagiri, and Naoki Ikawa, and Hiroaki Ishikawa, and Takashi Mine, and Makoto Take, and Mitsuru Haresaku, and Michiharu Matsumoto, and Shoji Fukushima
January 1982, Anticancer research,
Kenji Takanobu, and Shigetoshi Aiso, and Yumi Umeda, and Hideki Senoh, and Misae Saito, and Taku Katagiri, and Naoki Ikawa, and Hiroaki Ishikawa, and Takashi Mine, and Makoto Take, and Mitsuru Haresaku, and Michiharu Matsumoto, and Shoji Fukushima
December 1976, Journal of the National Cancer Institute,
Kenji Takanobu, and Shigetoshi Aiso, and Yumi Umeda, and Hideki Senoh, and Misae Saito, and Taku Katagiri, and Naoki Ikawa, and Hiroaki Ishikawa, and Takashi Mine, and Makoto Take, and Mitsuru Haresaku, and Michiharu Matsumoto, and Shoji Fukushima
September 2013, Journal of toxicologic pathology,
Kenji Takanobu, and Shigetoshi Aiso, and Yumi Umeda, and Hideki Senoh, and Misae Saito, and Taku Katagiri, and Naoki Ikawa, and Hiroaki Ishikawa, and Takashi Mine, and Makoto Take, and Mitsuru Haresaku, and Michiharu Matsumoto, and Shoji Fukushima
November 1988, Fundamental and applied toxicology : official journal of the Society of Toxicology,
Kenji Takanobu, and Shigetoshi Aiso, and Yumi Umeda, and Hideki Senoh, and Misae Saito, and Taku Katagiri, and Naoki Ikawa, and Hiroaki Ishikawa, and Takashi Mine, and Makoto Take, and Mitsuru Haresaku, and Michiharu Matsumoto, and Shoji Fukushima
May 1987, The Journal of toxicological sciences,
Kenji Takanobu, and Shigetoshi Aiso, and Yumi Umeda, and Hideki Senoh, and Misae Saito, and Taku Katagiri, and Naoki Ikawa, and Hiroaki Ishikawa, and Takashi Mine, and Makoto Take, and Mitsuru Haresaku, and Michiharu Matsumoto, and Shoji Fukushima
June 2002, Journal of experimental & clinical cancer research : CR,
Copied contents to your clipboard!